“…In this sense, mice with this genotype exhibit abnormal emotional responses ( Pedraza et al, 2014 ), cognitive alterations in hippocampus-dependent tasks ( Castilla Ortega et al, 2011 , 2014 ), anhedonia ( Moreno-Fernández et al, 2017 ), anxiety ( Santín et al, 2009 ), agitation, increased stress reactivity ( Pedraza et al, 2014 ; Moreno-Fernández et al, 2017 ) dysfunctional coping in response to chronic stress ( Castilla-Ortega et al, 2011 ) and fatigability, behaviours that are strongly associated with the psychopathological endophenotype of depression with anxious features ( Moreno-Fernández et al, 2017 ). Furthermore, from a neurobiological perspective, adult maLPA 1 -null mice exhibit impairments in hippocampal neurogenesis ( Matas-Rico et al, 2008 ), increased endocrine responses to emotional stimuli ( Pedraza et al, 2014 ), hypoactivity and dysregulation of the normal function of the hypothalamic–pituitary–adrenal (HPA) axis after chronic stress ( Castilla-Ortega et al, 2011 ), and dysfunctional changes among the highly interconnected ‘limbic’ regions and functional reorganisation of the brain network ( Moreno-Fernández et al, 2017 ), all of which are factors that have also been strongly correlated with depression ( Boucher et al, 2011 ) and anxiety ( Hakamata et al, 2017 ). Moreover, both the behavioural symptoms and the abnormal patterns of brain connectivity in maLPA 1 -null mice are normalised by antidepressant treatment ( Moreno-Fernández et al, 2017 ).…”